As of July 18, 2025, the Food and Drug Administration (FDA) said it has received three reports of fatal acute liver failure ...

US pharma major Bristol Myers Squibb’s shares remained steady, despite the company reporting disappointing results from its ...

The European Commission granted conditional marketing authorization for Ezmekly (mirdametinib) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN) in pediatric and adult patients ...

Danish allergy immunotherapy specialist ALK has announced that the UK’s Medicines and Healthcare Products Regulatory Agency ...

In what is not exactly a win-win situation for the Indian generic firms, a recent federal court ruling in Delaware, USA, has ...

Oncologic Drugs Advisory Committee has voted against two proposed combination regimens containing GSK’s Blenrep (belantamab ...

US healthcare giant Johnson & Johnson announced that the prestigious medical journal The Lancet has published positive ...

The market for selective estrogen receptor modulators, or SERMs, is poised for considerable growth over the next decade, ...

Japanese drug major Astellas Pharma has signed a memorandum of understanding with the Korea Institute of Startup and ...

Scottish biotech Trogenix has announced two senior appointments as the company advances its pipeline towards the clinic.

US precision immune-oncology firm I-Mab has entered into a definitive agreement to acquire 100% ownership of Bridge Health ...

The Institute for Clinical and Economic Review (ICER) has cast doubt on the value of a new spinal muscular atrophy treatment ...